Responses
Scientific Abstracts
Rheumatoid arthritis - other biologictreatment
SAT0129 Improved Quality of Life, Work Productivity, General Activity and Independence in Response to Subcutaneous Abatacept or Adalimumab in Rheumatoid Arthritis: Results from the Ample Trial
Compose a Response to This Article
Other responses
No responses have been published for this article.